Tirzepatide Weight Loss in San Antonio | From $250 | DaVida
Tirzepatide Weight Loss in San Antonio | From $250 | DaVida
Couldn't load pickup availability
Tirzepatide weight loss — the dual-action medication producing the most dramatic results.
Tirzepatide is a dual GLP-1 + GIP receptor agonist — the newest and most-effective FDA-approved weight loss medication on the market. The dual mechanism produces greater average weight loss than semaglutide in clinical trials, with similar tolerability. At DaVida Medical Aesthetics in San Antonio, our tirzepatide program is medically supervised, with low-dose and high-dose options to fit your goals and budget across 3-month and 6-month durations.
Why people reach for it
Tirzepatide is the first dual GLP-1 + GIP receptor agonist — meaning it activates two complementary metabolic pathways simultaneously, producing more weight loss than single-pathway medications in clinical trials.
Clinical trials show tirzepatide producing 15–20% body weight loss for most patients at the highest doses — measurably greater than semaglutide's 12–15% average. The dual mechanism is the difference.
Our pricing offers both low-dose (2.5–7.5mg) and high-dose (10–15mg) tiers — letting clients start lower and titrate up, or commit to high-dose for maximum results from the start.
Every tirzepatide program is supervised by a licensed provider — eligibility screening, dose titration, side-effect management, and ongoing monitoring throughout your treatment course.
Who it's for
Tirzepatide may be right for clients dealing with:
Why it works
Tirzepatide activates both GLP-1 and GIP receptors — two complementary metabolic pathways. The dual action produces stronger appetite suppression and more significant weight loss than single-receptor medications.
The GLP-1 portion mimics the body's natural appetite-regulating hormone — slowing gastric emptying, signaling fullness, and reducing food cravings between meals.
The GIP component provides the additional metabolic action — improving insulin response, reducing fat storage signals, and supporting the dual-pathway weight loss benefit unique to tirzepatide.
Doses titrate from low (2.5–7.5mg) to high (10–15mg) based on your response, tolerance, and goals. Your provider adjusts throughout the program to optimize results while managing side effects.
What to expect
- Initial consultation: medical history, eligibility screening, goal-setting
- Provider determines starting dose tier (low or high)
- Bloodwork if needed; prescription and injection training provided
- Begin weekly self-administered injections
- Weeks 1–4: Starting dose; body adjusts; tolerance assessed
- Weeks 4–12: Dose titration up if appropriate; significant weight loss begins
- Months 3–6: Sustained progress; many clients see 15–20% body weight reduction at higher doses
- Maintenance: continue, transition off, or move to lower-dose maintenance based on goals
Common questions
How much does Tirzepatide cost at DaVida?
Pricing depends on dose tier and duration. Starter pack: $250. 3-month: low dose (2.5–7.5mg) $849, high dose (10–15mg) $1,299. 6-month: low dose $1,650, high dose $2,550. Longer commitments and higher doses are priced for clients ready to commit to maximum results — the 6-month high-dose option produces the most dramatic outcomes.
What's the difference between low dose and high dose?
Low dose (2.5–7.5mg) is appropriate for clients starting tirzepatide, those with lower weight loss goals, or anyone wanting to confirm tolerance before committing to higher doses. High dose (10–15mg) produces the maximum weight loss documented in clinical trials but requires most patients to titrate up from a lower starting dose. Your provider determines appropriate starting and target doses.
Tirzepatide vs Semaglutide — which is better?
Both are excellent GLP-1 medications. Tirzepatide's dual GLP-1 + GIP mechanism produces somewhat greater weight loss on average — clinical trials show 15–20% vs semaglutide's 12–15%. Tirzepatide is also slightly newer with less long-term data. Semaglutide has the longer track record. The right choice depends on your goals, medical history, and how aggressive you want to be with your weight loss.
What are the common side effects?
Tirzepatide has a similar side-effect profile to semaglutide — primarily gastrointestinal (nausea, mild stomach upset, occasional constipation or diarrhea) particularly in early weeks or after dose increases. Most side effects resolve as your body adjusts. Serious side effects are rare but discussed during eligibility screening.
How quickly will I see results?
Initial weight loss typically begins within the first 4–8 weeks. Significant weight loss (10%+ of body weight) commonly occurs by months 3–6, particularly at higher doses. Maximum results from a full 6-month or 1-year program — clinical trials documented continued weight loss through 72 weeks of treatment at the highest dose.
Who isn't a candidate for tirzepatide?
Tirzepatide isn't appropriate for clients with personal/family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or pregnancy/breastfeeding. Eligibility is screened during your initial consultation by our supervising provider.
"Tirzepatide is the medication producing the most dramatic results in modern weight-loss medicine — the dual mechanism is genuinely unique and the clinical results back the price difference. Our medical supervision and tiered dosing structure make it accessible for clients ready to invest in significant transformation. Longer commitments + higher doses = the most life-changing outcomes we see at our practice."
- ✓Free shipping over $150
- ✓Authorized retailer
- ✓Aesthetician approved
- ✓San Antonio pickup available